Lilly’s tirzepatide secures first approval in diabetes, paving path for dual-acting hormone mimetics

Title
Lilly’s tirzepatide secures first approval in diabetes, paving path for dual-acting hormone mimetics
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-20
DOI
10.1038/d41573-022-00094-2

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now